On November 26th, NetDragon (00777) spent HKD 3.92 million to repurchase 340,000 shares.

17:40 26/11/2025

NetDragon (00777) announced that on November 26, 2025, the company invested HK$3.92 million ...

NETDRAGON (00777) announced on November 26, 2025 that the company will spend 3.92 million Hong Kong dollars to repurchase 340,000 shares, with a repurchase price of 11.45-11.61 Hong Kong dollars per share.

VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.

Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."

VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.

Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."